Literature DB >> 29406343

Intermediate-Term Hip Survivorship and Patient-Reported Outcomes of Periacetabular Osteotomy: The Washington University Experience.

Joel Wells1, Perry Schoenecker2,3, Stephen Duncan2,4, Charles W Goss2, Kayla Thomason2, John C Clohisy2.   

Abstract

BACKGROUND: The Bernese periacetabular osteotomy (PAO) is an alternative to arthroplasty for treating symptomatic acetabular dysplasia, but there have been few studies on the intermediate-term outcomes of this procedure. In the present study, we assessed intermediate-term hip survival and patient-reported outcomes of PAO used to treat symptomatic acetabular dysplasia.
METHODS: From July 1994 to August 2008, 238 hips (206 patients) were treated with PAO. Sixty-two had a diagnosis other than classic acetabular dysplasia, and 22 were lost to follow-up. The remaining 154 hips (129 patients) were evaluated at an average of 10.3 years postoperatively. Kaplan-Meier analysis was used to assess survivorship with an end point of total hip arthroplasty (THA). Hips were evaluated using the University of California at Los Angeles (UCLA) Activity Score, modified Harris hip score (mHHS), and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score. A WOMAC pain subscale score of ≥10 and/or an mHHS of ≤70 were considered to indicate a clinically symptomatic hip.
RESULTS: Kaplan-Meier analysis revealed a hip survival rate of 92% (95% confidence interval [CI]: 82% to 97%) at 15 years postoperatively. Eight hips (5%) underwent THA at a mean (and standard deviation) of 6.8 ± 5.2 years. Twenty-four additional hips (16%) were considered symptomatic based on a WOMAC pain score of ≥10 and/or an mHHS of ≤70. One hundred and twenty-two hips (79%) did not undergo THA and did not meet the criteria for symptoms, and these hips had a mean mHHS of 92.4 ± 8.4, WOMAC pain subscale score of 1.2 ± 1.9, and UCLA Activity Score of 7.7 ± 2.0 at a mean of 10.1 years. A higher risk of failure was associated with fair or poor preoperative joint congruency (odds ratio [OR]: 8.65; 95% CI: 1.18 to 63.55; p = 0.034) and with a postoperative lateral center-edge angle of >38° (OR: 8.04; 95% CI: 2.01 to 32.22). A concurrent head-neck osteochondroplasty was associated with a decreased risk of failure (OR: 0.27; 95% CI: 0.09 to 0.78; p = 0.016).
CONCLUSIONS: This study demonstrates the durability of the Bernese PAO. Fair or poor preoperative joint congruency and excessive postoperative femoral head coverage were found to be predictors of failure, while concurrent head-neck osteochondroplasty in patients with an inadequate range of motion after PAO was associated with a decreased risk of failure. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2018        PMID: 29406343     DOI: 10.2106/JBJS.17.00337

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  25 in total

1.  Patient Age and Hip Morphology Alter Joint Mechanics in Computational Models of Patients With Hip Dysplasia.

Authors:  Holly D Thomas-Aitken; Jessica E Goetz; Kevin N Dibbern; Robert W Westermann; Michael C Willey; Timothy S Brown
Journal:  Clin Orthop Relat Res       Date:  2019-05       Impact factor: 4.176

2.  CORR Insights®: Structured-mentorship Program for Periacetabular Osteotomy Resulted in Few Complications for a Low-volume Pelvic Surgeon.

Authors:  Benjamin F Ricciardi
Journal:  Clin Orthop Relat Res       Date:  2019-05       Impact factor: 4.176

3.  Are Complications After the Bernese Periacetabular Osteotomy Associated With Subsequent Outcomes Scores?

Authors:  Joel Wells; Perry Schoenecker; Jeff Petrie; Kayla Thomason; Charles W Goss; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2019-05       Impact factor: 4.176

4.  Structured-mentorship Program for Periacetabular Osteotomy Resulted in Few Complications for a Low-volume Pelvic Surgeon.

Authors:  Daud Tai Shan Chou; Lucian Bogdan Solomon; Kerry Costi; Susan Pannach; Oksana Tamara Holubowycz; Donald William Howie
Journal:  Clin Orthop Relat Res       Date:  2019-05       Impact factor: 4.176

5.  Combined Surgical Approach to Young Adults with Hip Dysplasia and Concomitant Intra-Articular Pathology Using Intra-Abdominal Monitoring.

Authors:  Robert J Wetzel; Noah M Joseph; Derrick M Knapik; Jonathan Copp; Michael J Salata
Journal:  Iowa Orthop J       Date:  2020

6.  Hip Arthroscopy Prior to Periacetabular Osteotomy Does Not Increase Operative Time or Complications: A Single Center Experience.

Authors:  Alan G Shamrock; Robert W Westermann; Trevor R Gulbrandsen; Zain M Khazi; Christopher N Carender; Michael C Willey
Journal:  Iowa Orthop J       Date:  2021

7.  Simultaneous femoral head reduction osteotomy (FHRO) combined with periacetabular osteotomy (PAO) for the treatment of severe femoral head asphericity in Perthes disease.

Authors:  Kaveh Gharanizadeh; Hadi Ravanbod; Amir Aminian; Seyed Peyman Mirghaderi
Journal:  J Orthop Surg Res       Date:  2022-10-20       Impact factor: 2.677

8.  What Mid-term Patient-reported Outcome Measure Scores, Reoperations, and Complications Are Associated with Concurrent Hip Arthroscopy and Periacetabular Osteotomy to Treat Dysplasia with Associated Intraarticular Abnormalities?

Authors:  Adam I Edelstein; Jeffrey J Nepple; Wahid Abu-Amer; Cecilia Pascual-Garrido; Charles W Goss; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2021-05-01       Impact factor: 4.176

9.  Is Previous Periacetabular Osteotomy Associated with Pregnancy, Delivery, and Peripartum Complications?

Authors:  Kimberly Bartosiak; Chris Stockburger; Jennifer Stockburger; Sara Putnam; Shayna Conner; John Clohisy
Journal:  Clin Orthop Relat Res       Date:  2020-01       Impact factor: 4.755

10.  What Proportion of Patients Undergoing Bernese Periacetabular Osteotomy Experience Nonunion, and What Factors are Associated with Nonunion?

Authors:  Courtney M Selberg; Ariel D Davila-Parrilla; Kathryn A Williams; Young-Jo Kim; Michael B Millis; Eduardo N Novais
Journal:  Clin Orthop Relat Res       Date:  2020-07       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.